Volume 22, Issue 2 , Pages 317-329, April 2008
The benefits of early androgen blockade
Altering the effects of testosterone on prostate cancer cells by blocking androgen production or action is a critical part of treating this malignancy. The appropriate timing of androgen blockade for advanced prostate cancer is controversial. Despite many phase-III studies, gaps in clinical information still remain, and some questions are still not conclusively answered. This review concentrates on high-level evidence to address common clinical situations in advanced and metastatic prostate cancer. Additionally, the side-effects of androgen blockade have become increasingly visible and relevant.
Key words: prostate cancer, hormonal therapy
To access this article, please choose from the options below
PII: S1521-690X(08)00014-6
doi:10.1016/j.beem.2008.01.013
© 2008 Elsevier Ltd. All rights reserved.
Volume 22, Issue 2 , Pages 317-329, April 2008
